Patents by Inventor Huo-Shu H. Houng

Huo-Shu H. Houng has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 6793488
    Abstract: A fluorescent DNA probes specific to the conserved terminal 3′-noncoding region (nucleotides 10653-10678) of dengue virus and a pair of flanking primers are designed to formulate a dengue specific fluorogenic polymerase chain reaction (PCR). Optimal assay conditions with zero background are disclosed which permit the detection of low levels of dengue virus from clinical specimens. Dengue virus isolates from different geographic regions can be universally detected and identified by the fluorogenic RT-PCR assay. Moreover, the assay is specific for dengue 2 virus and does not recognize other related flaviviruses, including dengue serotypes Louis encephalitis, yellow fever, and Kunjin viruses. The ) 3, and 4, Japanese encephalitis, St. assay also efficiently detected immunocomplexed dengue viruses. The fluorogenic RT-PCR assay readily detected viremia in sera collected from individuals ill with dengue fever.
    Type: Grant
    Filed: April 14, 2000
    Date of Patent: September 21, 2004
    Assignee: U.S. Army Medical Research & Materiel Command
    Inventors: Huo-Shu H. Houng, Niranjan Kanesa-Thasan
  • Patent number: 5958686
    Abstract: A simple polymerase chain reaction procedure is described for the detection and differentiation of Shigella from other pathogenic Escherichia coli isolates, such as EIEC and EPEC. Serotype specific primers derived from the rfc genes of different Shigella strains are used to identify the most prominents Shigella serotypes, such as S. sonnei, S. flexneria 1 through 5, and S dysenteriae 1. More than 95% of Shigellosis cases reported could be identified by the serotype specific primers described.
    Type: Grant
    Filed: October 28, 1996
    Date of Patent: September 28, 1999
    Assignee: The United States of America as represented by the Secretary of the Army
    Inventor: Huo-Shu H. Houng
  • Patent number: 5939075
    Abstract: The vaccines are prepared by isolating the Brucella genes complementing mutations in the purEK genes of Escherichia coli, physically mapping, determining the DNA sequence, constructing a defined deletion mutation by polynucleotide chain reaction (PCR), introducing a selectable marker into the deletion, and then selecting a purE mutant in Brucella arising by allelic exchange. The resulting Brucella require purines for growth because they lack the purE gene product that is required for the carboxylation of 5'-phosphoribosyl-5-aminoimidazole.
    Type: Grant
    Filed: May 8, 1997
    Date of Patent: August 17, 1999
    Assignee: The United States of America as represented by the Secretary of the Army
    Inventors: Huo-shu H. Houng, Richard L. Warren